Castelvecchio Pascoli (Lucca) – 05 October 2020 – The Board of Directors of Kedrion S.p.A. is pleased to welcome Val Romberg as the new CEO of Kedrion. Val Romberg’s career has spanned over nearly forty years in the pharmaceutical industry – specifically in the plasma derivatives sector – in companies such as CSL Behring, West Pharmaceutical Services and Aventis Behring. His last position, which ended in 2019, was as Executive Vice President, Manufacturing and Planning.
Paolo Marcucci will continue to be Chairman of the company and will remain in charge of Strategy, Business Development, and External Relations. Mr. Marcucci said: "Val Romberg's leadership skills and experience – particularly in Operations, R&D and Manufacturing – make him a great fit with the mission and values of our company."
Mr. Marcucci added: “Mr. Romberg’s knowledge and authority in the plasma industry will ensure a valuable guide to Kedrion for a successful future. Val Romberg will be completely dedicated to managing the challenges outlined in our strategic plans and has the full support of the Board of Directors and of all Kedrion’s shareholders. I am looking forward to working with Val and live together this new season of our company.”
